REX-001
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for REX-001, covering 2021-05-07 to 2023-03-16. Get the full timeline:
Most recent: Clinical Trial Update: The Efficacy and Safety of REX-001 to Treat Ischemic Ulcers in Subjects With CLI Rutherford Category 5 and DM [Phase 3]